China for mechanism with India, B'desh to share Brahmaputra waters

October 10, 2016

Beijing, Oct 10: Refuting reports of China joining water wars between India and Pakistan by blocking a tributary of Brahmaputra river, Chinese official media said today that Beijing is ready to join a multilateral cooperation mechanism with India and Bangladesh to share the waters.

brahmaputra

Relations between China and India should not be affected by "imaginary water war", an article in the state-run Global Times said, adding that Beijing is unlikely to use Brahmaputra river water as a potential weapon.

The article said China is willing to have multilateral cooperation with India and Bangladesh to share the waters. The proposal is significant as China has no water treaty with India to share the river waters.

"It is easy to understand the anger of Indian people as they read recent news reports saying China had blocked a tributary of the Brahmaputra river, which is a trans-boundary river flowing from Southwest China's Tibet Autonomous Region into the northeastern Indian state of Assam and later into Bangladesh, serving as an important water source for the regions," it said.

"The move by China to temporarily blockade the tributary to construct a dam sparked widespread concerns in India, but people in the downstream country may be ignoring one thing," it said, adding that the reservoir capacity of the dam on the Xiabuqu river, a tributary of the Brahmaputra, is less than 0.02 per cent of the average annual runoff of the Brahmaputra.

"Frankly, there is no need for India to overreact to such projects, which aim to help with reasonable development and utilisation of water resources," it said. However, what is worrying is that some local Indian media outlets linked the blockage with India's recent water dispute with Pakistan, trying to create the false impression that China may be interested in taking part in the "so-called water war between the two South Asian countries to give Pakistan silent support," the article stated. "However, construction of the dam project on the tributary of the Brahmaputra started in June 2014," it added.

"It is clear the blockade to construct the dam does not target India, and relevant countries should not read too much into the move," the write-up maintained. While it is understandable that India is sensitive to China's water exploitation on the Brahmaputra as a downstream country, "China is unlikely to use the waters of the river as a potential weapon," it said.

Pointing that China is the source of several trans-boundary rivers including the Lancang-Mekong River, which runs through China, Myanmar, Laos, Thailand, Cambodia and Vietnam, it said, "If China blocked the Brahmaputra for political reasons, such a move would cause panic among the five Southeast Asian nations and therefore damage China's relationship with them."

The article said there are cooperation mechanisms for China and the five Southeast Asian countries that can help coordinate sustainable use of water resources in the Lancang-Mekong River and share information.

"We believe that China is willing to borrow from the experience of this mechanism when it comes to promoting cooperation among the Brahmaputra's three major riparian countries. This will be the most effective solution to the water dispute between China and India," it said.

"Realistically, people may need to make efforts to persuade India, rather than China, to accept a multilateral cooperation mechanism involving all of the Brahmaputra's riparian countries," it added.

At the same the article has accused India of "making increasing efforts to exploit the Brahmaputra River through various forms", in a bid to develop the river's water resources.

"Some efforts may have harmed the interests of downstream Bangladesh, but the lack of bargaining power for Bangladesh, whose economy is highly dependent on India, has resulted in limited public attention," it said.

"India may feel reluctant to establish a cooperation mechanism among the Brahmaputra's riparian countries because such a mechanism is likely restrain India from moves that might hurt Bangladesh's interests," it said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 1,2020

Mexico City, Aug 1: The number of people, who have died of COVID-19 in Mexico, has risen by 688 to 46,688 within the past 24 hours, Deputy Health Minister Hugo Lopez-Gatell said.

The number of victims in Mexico is now higher than in the United Kingdom, where 46,119 people have died of the disease. The largest number of fatalities - 153,311 - has been recorded in the United States, while Brazil comes second with 92,475 deaths.

Lopez-Gatell also said on late Friday that the number of confirmed coronavirus cases had increased by 8,458 to 424,637 over the past day.

A day earlier, the Latin American nation recorded 7,730 new cases of the coronavirus, with 639 fatalities.

The World Health Organisation (WHO) declared the COVID-19 outbreak a pandemic on March 11. To date, over 17.5 million people have been infected with the coronavirus worldwide, with over 677,000 fatalities, according to Johns Hopkins University.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 21,2020

Rome, Mar 21: Italy on Friday reported a record 627 new deaths from the novel coronavirus, taking its overall toll past 4,000 as the pandemic gathered pace despite government efforts to halt its spread.

The total number of deaths was 4,032, with the number of infections reaching 47,021.

Italy's previous one-day record death toll was 475 on Wednesday.

The nation of 60 million now accounts for 36.6 percent of the world's coronavirus deaths.

Italy has seen more than 1,500 deaths from COVID-19 in the past three days alone.

Its current daily death rate is higher than that officially reported by China at the peak of its outbreak around Wuhan's Hubei province.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.